The agency on Tuesday authorized Swedish Match to say eight of its General snus smokeless tobacco products “puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis” than smoking. This marks the first time the FDA has approved this type of request, known as a modified-risk tobacco product application. Continued
No comments:
Post a Comment